Titan Bio-Tech Q2 Results FY27: Revenue Up 40.65% to Rs 76.46 Cr, PAT Rs 12.55 Cr

Titan Bio-Tech Ltd (TITANBIO) Q2 Results FY27 announced on 5 November 2026, covering the company's financial performance for the July to September quarter. The results date of 5 November 2026 brings revenue of Rs 76.46 Cr and PAT of Rs 12.55 Cr. Titan Bio-Tech Q2 Results FY27 therefore pair a 40.65% rise in revenue with a 61.52% rise in net profit.

This Univest results analysis of Titan Bio-Tech Q2 Results covers the financial highlights, business drivers, outlook and risks for the quarter. The Financial Highlights table that follows sets the figures side by side before the narrative turns to what stands out. It also explains how the quarterly results sit beside the return on equity reported for FY26.

Click Here – Get Free Investment Predictions

Titan Bio-Tech Q2 Results FY27: Financial Highlights

Metric	Q2 FY27 (Sep 26)	Q2 FY26 (Sep 25)	YoY Change
Revenue	Rs 76.46 Cr	Rs 54.36 Cr	+40.65% YoY
Net Profit (PAT)	Rs 12.55 Cr	Rs 7.77 Cr	+61.52% YoY

Source: company filing for Titan Bio-Tech Q2 Results FY27, 5 November 2026. Figures in Rs Crore.

Key Takeaways from Titan Bio-Tech Q2 Results: What Stands Out

• Revenue: Revenue rose 40.65% YoY to Rs 76.46 Cr from Rs 54.36 Cr, which is the starting point for the quarterly results and the largest single move in the quarter.
• Net profit: Net profit rose 61.52% YoY to Rs 12.55 Cr from Rs 7.77 Cr, so net profit grew faster than revenue over the year.
• Net profit margin: Net profit margin improved to 16.4% from 14.3% in the comparison quarter, which shows that profit grew by more than sales did.
• Reporting period: Titan Bio-Tech Q2 Results FY27 cover July to September 2026 and were declared on 5 November 2026.
• Return on equity: Return on equity was 16.39% in FY26, which the risks section below places beside the strong quarter.

Titan Bio-Tech Q2 Results FY27: Performance Analysis

The numbers show strong growth in both revenue and net profit over the year. Titan Bio-Tech reported revenue of Rs 76.46 Cr, up 40.65% YoY, and net profit of Rs 12.55 Cr, up 61.52% YoY. This results analysis therefore reads as a quarter in which profit grew faster than sales, and in which both lines moved up by a wide margin.

The comparison quarter supplies the base for that growth. A year earlier the company reported revenue of Rs 54.36 Cr and net profit of Rs 7.77 Cr, so the latest quarter adds Rs 22.10 Cr of revenue and Rs 4.78 Cr of net profit to those levels. Titan Bio-Tech Q2 Results FY27 thus show a clearly higher revenue and profit base than the comparison quarter, as the quarterly results confirm.

The gap between the 40.65% revenue growth and the 61.52% net profit growth is the main feature of the quarter. That makes Titan Bio-Tech Q2 Results a quarter in which profit outpaced sales, and the improvement in net profit margin from 14.3% to 16.4% is the clearest sign of it. The supplied figures confirm what changed but do not establish the specific cause, which is where the results analysis turns to the business factors.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue Growth – The results analysis points first to revenue, which grew 40.7% year on year to Rs 76.46 Cr in the latest quarter. This growth is the first business factor recorded in the quarterly results for Titan Bio-Tech Q2 Results FY27, and it is large enough to dominate the comparison with the quarter a year earlier.

Net Profit Growth – Net profit rose 61.5% year on year to Rs 12.55 Cr, which is a faster rate than revenue growth over the same period, so profit grew alongside sales and at a higher pace. The same figures show how the 61.5% profit growth compares with the 40.7% revenue growth in the latest quarter.

Net Profit Margin – Net profit margin improved to 16.4% from 14.3% in the comparison quarter, which means each rupee of revenue left a larger share as net profit than it did a year earlier. This margin gain is the link between the revenue growth and the faster net profit growth described above.

FY27 Outlook After Titan Bio-Tech Q2 Results

FY27 full-year results will depend on the quarters that follow, and the quarter reported on 5 November 2026 is one input among several. Titan Bio-Tech Q2 Results FY27 supply revenue of Rs 76.46 Cr and net profit of Rs 12.55 Cr as reference points for that comparison. Readers can set the 16.4% net profit margin and the 61.52% YoY net profit growth beside those figures when the next set of results arrives.

Readers following this results analysis can compare each later quarter with these figures, including the improved margin, using the Univest Screener. Subsequent disclosures and sector conditions will shape how the FY27 numbers build up, and the risks below describe what the data flags for attention.

Key Risks to Watch After Titan Bio-Tech Q2 Results FY27

Volatile Quarterly Revenue

Quarterly revenue has swung between Rs 48.83 Cr and Rs 76.46 Cr over the last 5 quarters. That range means a single quarter of strong growth is best read alongside the others, since Titan Bio-Tech Q2 Results FY27 sit at the top of it.

Margin Dependence

Net profit grew faster than revenue because net profit margin moved from 14.3% to 16.4%. That means the quarter's profit growth rests partly on the margin gain, so later quarterly figures are worth tracking to see whether the 16.4% level holds. The margin figures cover the two quarters compared here.

Full-Year Return Reference

Return on equity was 16.39% in FY26. This ratio describes the year before the latest quarter and is worth tracking alongside YoY growth in later quarterly figures. It belongs to the full year rather than to this single quarter.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Titan Bio-Tech Q2 Results FY27 combine a 40.65% rise in revenue to Rs 76.46 Cr with a 61.52% rise in net profit to Rs 12.55 Cr. These figures show higher sales, higher profit and a better net profit margin over the year. For anyone tracking Titan Bio-Tech Q2 Results, the quarterly results are best read with the risks above, and investors should consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Titan Bio-Tech Q2 Results FY27

What are Titan Bio-Tech Q2 Results FY27?

Ans. Titan Bio-Tech Q2 Results FY27 are the quarterly results for July to September 2026, showing revenue of Rs 76.46 Cr and net profit of Rs 12.55 Cr, as summarised in the Quick Answer at the top.

What is the results date for Titan Bio-Tech Q2 Results FY27?

Ans. The results date for Titan Bio-Tech Q2 Results FY27 is 5 November 2026, which means the figures cover the July to September 2026 quarter, as the opening paragraphs explain.

What revenue was reported in Titan Bio-Tech Q2 Results FY27?

Ans. Titan Bio-Tech reported revenue of Rs 76.46 Cr in the quarter, compared with Rs 54.36 Cr a year earlier, as shown in the Financial Highlights table above.

What net profit was reported in Titan Bio-Tech Q2 Results FY27?

Ans. Titan Bio-Tech reported net profit of Rs 12.55 Cr for the quarter, compared with Rs 7.77 Cr a year earlier, which the Performance Analysis section covers in more detail.

How much YoY growth did revenue show in Titan Bio-Tech Q2 Results FY27?

Ans. Revenue showed YoY growth of 40.65% in the quarter, rising from Rs 54.36 Cr to Rs 76.46 Cr, as the Performance Analysis section explains in its first two paragraphs.

Did net profit rise or fall in Titan Bio-Tech Q2 Results?

Ans. Net profit rose 61.52% YoY in the quarter, from Rs 7.77 Cr to Rs 12.55 Cr, while revenue also rose, so the Key Takeaways section treats both lines as growing.

How fast did net profit grow compared with revenue in Titan Bio-Tech Q2 Results FY27?

Ans. Net profit grew 61.52% YoY while revenue grew 40.65%, which means profit growth was faster than sales growth, as the Key Business Factors section notes.

What was the net profit margin in Titan Bio-Tech Q2 Results?

Ans. Net profit margin improved to 16.4% from 14.3% in the comparison quarter, which means profit grew by more than sales did, as the Key Business Factors section lists.

What business factors shaped Titan Bio-Tech Q2 Results FY27?

Ans. Revenue growth of 40.7% year on year, net profit growth of 61.5% and a margin gain to 16.4% shaped the picture, while the Key Business Factors section sets out each one.

What are the key risks after Titan Bio-Tech Q2 Results FY27?

Ans. The key risks are volatile quarterly revenue between Rs 48.83 Cr and Rs 76.46 Cr, dependence on the margin gain and a return on equity of 16.39% in FY26, as the Key Risks section lists.

What is the outlook after Titan Bio-Tech Q2 Results?

Ans. FY27 full-year results will depend on the quarters that follow, so revenue of Rs 76.46 Cr and net profit of Rs 12.55 Cr serve as the reference points listed in the Outlook section.

Where can I find the complete Titan Bio-Tech Q2 Results FY27 data?

Ans. The complete Titan Bio-Tech Q2 Results FY27 data sits in the Financial Highlights table above, while the Univest app lets investors follow later quarterly results for the stock alongside these figures.